Clinical Trial Update: A Randomized, Open, Parallel, Optimal Injection Rate-Finding Study for E7337 in Dynamic CT of the Liver in Patients With Liver Disease [Phase 2]

View source ↗

Summary

A Phase 2 randomized, open-label study evaluated the optimal injection rate of E7337 for dynamic CT imaging of the liver in patients with liver disease; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• E7337

Snippet

Sponsor: Eisai Limited | Conditions: Lesion | Phase 2 | Status: COMPLETED